electroCore (ECOR) to Release Earnings on Monday
electroCore opened at $13.16 on Friday, according to Marketbeat Ratings. electroCore has a 52-week low of $12.85 and a 52-week high of $20.25.
In related news, major shareholder Global Health Innovation Merck acquired 166,666 shares of the business’s stock in a transaction dated Thursday, June 21st. The shares were purchased at an average price of $15.00 per share, for a total transaction of $2,499,990.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.
electroCore Company Profile
electroCore, LLC, a bioelectronic medicine company, engages in developing a range of patient-administered non-invasive vagus nerve stimulation therapies for the treatment of various conditions in neurology, rheumatology, and other fields. It is developing gammaCore, a prescription-only vagus nerve stimulation therapy, for the acute treatment of pain associated with migraine and episodic cluster headache in adults.
Further Reading: Stock Symbol
Receive News & Ratings for electroCore Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for electroCore and related companies with MarketBeat.com's FREE daily email newsletter.